How to Test Methylation and Interpret Your Results

Methylation testing is not a single test but a family of very different assessments, each measuring a distinct aspect of how your body adds and removes methyl groups from DNA and other molecules. Some tests look at your genes to see whether you carry variants that slow down key enzymes. Others measure the downstream products in your blood, like homocysteine, to gauge whether the whole system is running smoothly. Still others scan your actual DNA methylation patterns to estimate your biological age. Understanding which test does what, and what the numbers genuinely mean, is the difference between actionable health information and expensive confusion.

The Three Categories of Methylation Testing

When people talk about “testing methylation,” they could mean any of three fundamentally different things, and the distinction matters because each type answers a different question about your health.

The first category is genetic testing, most commonly for variants in the MTHFR gene. This tells you whether you carry mutations that reduce the activity of an enzyme involved in processing folate and recycling homocysteine. It is a fixed result: your MTHFR status never changes, so you only need to test once. The second category is blood biomarker testing, where a lab measures circulating levels of molecules like homocysteine, S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), folate, and vitamin B12. These are functional snapshots that fluctuate with your diet, supplement use, and overall health. The third category is epigenetic testing, where specialized assays read the methylation marks on your DNA itself, often to calculate a “biological age” using algorithms called epigenetic clocks. Each of these deserves its own discussion, because interpreting results from one type as if they came from another is a common mistake.

MTHFR Genetic Testing

The MTHFR gene codes for an enzyme called methylenetetrahydrofolate reductase, which converts one form of folate into the active form your body uses for methylation reactions. Two common variants get most of the attention. The C677T variant swaps one amino acid in the enzyme, reducing its activity and making it less stable at body temperature. The A1298C variant causes a different amino acid change with a milder effect on its own.

What matters is how many copies of these variants you carry. People who are homozygous for C677T (meaning they inherited the variant from both parents) have the most reduced enzyme activity. People who carry one copy of each variant (compound heterozygotes, roughly one in seven people) show enzyme activity around half of normal levels.

Here is where expectations and reality diverge. The internet is full of claims that MTHFR variants explain everything from chronic fatigue to infertility, but major medical organizations take a far more measured view. Both the American College of Medical Genetics and Genomics and the American College of Obstetricians and Gynecologists recommend against routine MTHFR screening, stating that these tests lack clinical utility and do not change patient management for conditions like blood clotting disorders, recurrent pregnancy loss, or elevated homocysteine.

That recommendation does not mean the variants are meaningless. It means that for most people, the right response to elevated homocysteine is the same regardless of MTHFR status: ensure adequate folate, B12, and B6 intake. Testing your MTHFR genes tells you about your predisposition but does not tell you how your body is actually performing right now, which is why functional biomarkers are usually more informative for everyday health decisions.

Blood Biomarkers That Reflect Methylation Status

If genetic testing tells you about your hardware, blood biomarkers tell you how the software is actually running. The most commonly ordered marker is homocysteine, an amino acid that accumulates when methylation pathways are sluggish. Your doctor can order a simple fasting blood test through any standard lab. Most reference ranges consider levels below about 15 micromoles per liter normal, though many functional medicine practitioners prefer to see levels below 10.

Beyond homocysteine, specialty labs can measure SAM and SAH directly. SAM is the molecule your body uses as the methyl donor for hundreds of different reactions, from building neurotransmitters to silencing genes. When SAM donates its methyl group, it becomes SAH, which actually inhibits methylation enzymes if it builds up too much. The ratio of SAM to SAH has been studied as a more sensitive indicator of methylation capacity than either molecule alone, and research has linked a lower SAM-to-SAH ratio to conditions like atherosclerosis.

Other useful markers include serum folate and red blood cell folate (the latter reflects longer-term status), vitamin B12, and sometimes methylmalonic acid, which rises when B12 is functionally low even if serum B12 looks normal. Taken together, these tests paint a picture of whether your one-carbon metabolism is well supplied or running into bottlenecks.

One practical note: SAM is notoriously unstable in blood samples. It degrades quickly at room temperature, so proper collection and handling matter. If your SAM level comes back suspiciously low, it is worth asking whether the sample was processed on ice and frozen promptly, because a mishandled tube can give a misleadingly low reading.

⁴

Epigenetic Clocks and Biological Age Testing

A newer and increasingly popular form of methylation testing skips genes and blood chemistry entirely and instead reads the methylation marks scattered across your DNA. At specific spots on your genome, methyl groups are added or removed as you age, and researchers have identified patterns so consistent that algorithms can estimate your biological age from a blood sample. These algorithms, known as epigenetic clocks, include models like Horvath, Hannum, PhenoAge, and GrimAge, each trained on different data and optimized to predict slightly different outcomes.

⁵

All of them work by measuring methylation levels at a set of CpG sites (spots in the genome where cytosine sits next to guanine) and feeding those measurements into a statistical model. Early clocks like Horvath’s tracked chronological age closely. Later clocks like GrimAge were designed to predict health outcomes and mortality risk, making them more clinically interesting if you want to know how fast your body is aging rather than just confirming your birthday.

⁶

Several direct-to-consumer companies now offer epigenetic age tests. You typically receive a kit, provide a blood sample (some accept saliva, though blood is generally considered more reliable for these assays), and get back a report showing your estimated biological age alongside your chronological age. If your biological age is lower, the interpretation is that your methylation patterns resemble those of a younger person. If it is higher, the reverse.

Recent work has pushed toward simpler, cheaper versions of these clocks. One study demonstrated a 12-site assay that could predict age with strong accuracy, achieving correlations with chronological age above 0.83 at each measured site and prediction errors in the range of three to five years.

⁷

What Elevated Homocysteine Actually Means

Homocysteine is the methylation biomarker your doctor is most likely to order and the one with the longest track record of clinical research. Elevated levels, a condition called hyperhomocysteinemia, have been studied extensively as a risk factor for cardiovascular disease. The proposed mechanisms include damage to blood vessel linings, promotion of inflammation, increased clotting tendency, and acceleration of plaque buildup in arteries.

⁸

The nervous system is also affected. High homocysteine has been linked to cognitive decline and stroke independently of traditional risk factors like high cholesterol, high blood pressure, and diabetes.

⁹ The mechanisms are wide-ranging, involving overactivation of certain brain receptors, disruption of calcium handling in cells, and increased production of inflammatory molecules.¹⁰

That said, an important caveat has emerged from clinical trials: lowering homocysteine with B vitamins does not reliably prevent heart attacks or strokes in people who already have cardiovascular disease. The relationship between homocysteine and disease may be partly a marker of poor methylation and nutrient status rather than a direct cause you can fix with a single supplement. This is why the result is still useful, it flags a metabolic imbalance worth investigating, but interpreting a high homocysteine level as a direct cardiovascular threat that B vitamins alone will fix oversimplifies the picture.

Why Methylation Patterns Matter Beyond Aging

Methylation does far more than mark your biological age. In mammals, DNA methylation is a primary mechanism for silencing stretches of the genome that should not be active, including transposable elements (sometimes called “jumping genes”) that could destabilize your chromosomes if left unchecked. Methylation also keeps certain genes turned off in a sex-specific or parent-of-origin-specific way.

¹¹

When global methylation levels drop too low, the consequences can extend to cancer risk. Research in animal models has shown that loss of methylation at repetitive DNA elements leads to genomic instability and can initiate tumor formation in the intestines.

¹² In human studies, global DNA hypomethylation in ovarian cancer tumors has been associated with more advanced disease, greater chromosomal instability, and worse survival outcomes.¹³

This does not mean a consumer methylation test can predict your cancer risk. The tests available to the public measure different things at different scales than what researchers study in tumor tissue. But the underlying biology explains why clinicians and researchers care about methylation beyond the wellness context: it is a fundamental regulatory mechanism, and when it goes wrong, the downstream effects can be severe.

Limitations You Should Know Before Ordering Tests

Every methylation test has blind spots, and understanding them helps you avoid over-interpreting your results. For blood-based DNA methylation assays, the biggest confounder is cell type composition. Your blood contains a mix of different white blood cell types, and each type has its own methylation signature. If your sample happens to have a higher proportion of one cell type than another (due to a recent infection, chronic inflammation, or just natural variation), the methylation readout shifts accordingly. Researchers have developed statistical methods to adjust for this, but not all consumer tests apply them.

¹⁴

For epigenetic clocks specifically, technical variability is another concern. The arrays used to measure methylation at hundreds of thousands of sites are generally reproducible, but clock estimates can fluctuate depending on laboratory conditions. Research has found that when replicate samples were processed on different slides within the same lab run, some clocks dropped from “good” to only “moderate” reliability. DNA extraction methods can also introduce noise.

¹⁵

The practical implication: if you test your biological age twice within a few weeks and get results that differ by two or three years, that difference might be technical noise rather than a real biological change. If you are tracking your biological age over time to see whether a lifestyle intervention is working, use the same lab and same test version each time to minimize this variability. And be cautious about drawing conclusions from a single test.

When MTHFR Testing Actually Changes Treatment

Although routine MTHFR screening is not recommended for the general population, there is one clinical scenario where knowing your genotype can make a tangible difference: if you are prescribed methotrexate. This drug, used for conditions ranging from ectopic pregnancy to autoimmune diseases and certain cancers, works in part by interfering with folate metabolism. People with MTHFR variants that already reduce folate processing can experience slower clearance of the drug, leading to toxic buildup.

¹⁶

A study in pediatric patients found that carrying the C677T variant was associated with roughly 1.5 to 1.7 times higher risk of liver damage and mucosal damage from methotrexate compared to patients without the variant.

¹⁷ In these situations, knowing someone’s MTHFR status before starting treatment can help clinicians adjust dosing or choose alternative therapies. This is pharmacogenomics in action: the test gains clinical utility not as a general wellness screen but within a specific prescribing decision.

The Folate and Choline Connection

If your methylation biomarkers come back looking suboptimal, the conversation usually turns to folate and B vitamins. But there is a parallel pathway that gets less attention: choline. Your body can use choline (through its metabolite betaine) as an alternative methyl donor, and these two pathways, folate-dependent and choline-dependent, compensate for each other to a degree. When folate intake is low, the body leans more heavily on choline, and vice versa. Animal studies have demonstrated that supplemental betaine can rescue not only plasma betaine levels but also plasma folate levels during deficiency, highlighting how intertwined these pathways are.

¹⁸

For you, this means that interpreting methylation test results in isolation from your overall diet misses half the picture. Someone with a mild MTHFR variant and adequate choline intake might have perfectly normal homocysteine levels. Someone with no genetic variants but a diet low in both folate and choline could show elevated homocysteine. When reviewing your results, consider both sides of the methyl donor equation.

Environmental Exposures That Alter Your Methylation Profile

Your methylation pattern is not just a product of your genes and diet. Environmental exposures leave measurable marks on the epigenome, and air pollution is one of the best-studied examples. Traffic-related pollutants including particulate matter, black carbon, ozone, and nitrogen oxides have all been associated with changes in DNA methylation, typically lowering it after exposure.

¹⁹

These are not abstract changes. A study of long-term air pollution exposure identified hundreds of differentially methylated regions in people living in high-pollution areas, concentrated in genes related to immune response and mitochondrial function. Participants in the higher pollution group also showed elevated levels of the inflammatory marker interleukin-5.

²⁰

This matters for interpretation because if you live in a high-traffic urban area, your methylation results may partly reflect your environment rather than your nutrition or genetics alone. It also means that interventions focused solely on supplements might not move the needle as much as expected if environmental exposures are driving some of the methylation changes you are seeing.

Can You Reverse Your Epigenetic Age

One of the most provocative questions in methylation testing is whether the biological age reading on your report can actually be pushed backward. A small randomized controlled trial tested an eight-week program combining a plant-rich diet, supplementation (including methylfolate, betaine, and probiotics), exercise, sleep optimization, and relaxation practices. The treatment group showed a decrease of about 3.2 years in their Horvath epigenetic age compared to the control group.

²¹

That is an exciting headline, but some perspective is warranted. The study was small, included only healthy adult men, and the within-group change, while trending in the right direction, did not quite reach conventional statistical significance. The technical variability of epigenetic clocks discussed earlier means that a shift of two or three years sits uncomfortably close to the measurement noise. Larger, longer trials are needed before anyone can confidently say that a specific protocol reliably turns back the epigenetic clock.

Still, the general direction is consistent with what we know about methylation biology. Diet and lifestyle choices genuinely influence methylation patterns, even if the precise magnitude of effect remains uncertain. If you are testing your biological age to track the impact of lifestyle changes, the most honest approach is to look for consistent trends across multiple tests over months or years rather than reading too much into a single snapshot.

Putting a Testing Plan Together

If you want a practical starting point, the most broadly useful first step for most people is a standard homocysteine blood test along with serum B12 and folate. These are inexpensive, widely available, and give you a functional read on whether your one-carbon metabolism has any obvious bottlenecks. If homocysteine comes back elevated, the standard next move is to optimize your intake of folate, B12, and B6, then retest in a couple of months to see if the number responds.

MTHFR genetic testing makes sense if you are curious about your predisposition, if you have a family history of very high homocysteine that does not respond to standard supplementation, or if you are facing a medication decision where MTHFR status could affect drug metabolism. It does not make sense as a standalone screening test in the absence of those situations.

Epigenetic age testing is the newest and most experimental of the three categories. It can be a motivating tool for people who respond well to data-driven feedback on their lifestyle choices, but you should go in with realistic expectations about precision and remember that the field is still working out which clock is most clinically meaningful and how much test-to-test variability you should expect.

For any of these tests, the result is only as useful as your ability to act on it. A homocysteine number without context about your diet, supplement use, and kidney function is just a number. A biological age readout without baseline and follow-up measurements is a curiosity, not a trend. And a genetic variant without knowledge of your actual nutrient status tells you about risk, not reality. The most informative approach combines more than one type of measurement so you can see the whole system, not just one piece of it.